EVIDENCE FOR A SPECIFIC POSTTRANSCRIPTIONAL MECHANISM CONTROLLING THE EXPRESSION OF HLA-DQ, BUT NOT HLA-DR AND HLA-DP, MOLECULES

被引:0
作者
BARBARO, AD [1 ]
SARTORIS, S [1 ]
TOSI, G [1 ]
NICOLIS, M [1 ]
ACCOLLA, RS [1 ]
机构
[1] UNIV VERONA,POLICLIN BORGO ROMA,SCH MED,INST IMMUNOL & INFECT DIS,I-37100 VERONA,ITALY
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is generally believed that the various MHC class II molecules are expressed coordinately in B cells. To investigate this aspect in more detail, interspecies somatic cell hybrids were constructed between Raji or RJ 2.2.5 (a class II-negative derivative of Raji) human B cells and M12.4.1 mouse B cells. In both types of hybrids, HLA-DR and -DP, but not -DQ, molecules were expressed at the cell surface. The specific lack of expression of DQ Ags correlated with undetectability of newly synthesized DQ alpha beta heterodimers, as assessed by biosynthetic labeling and immunoprecipitation with a variety of DQ-specific mAbs. Studies at the mRNA level showed that apparently normal DQ alpha and DQ beta transcripts were present in the hybrids at levels comparable, if not higher, with the levels of DR- and DP-specific transcripts. From these results, we conclude that lack of appreciable amount of DQ molecules in the hybrids is caused by a post-transcriptional block. To date, these findings represent a rather unique example of noncoordinate expression of MHC class II Ags caused by distinct post-transcriptional mechanisms. These data may be relevant to a more correct interpretation of the functional role of the various MHC class II molecules, particularly with regard to the well-known association of HLA-DQ with many autoimmune diseases. Possible mechanisms at the basis of the distinct control of expression within the MHC class II molecular pool are discussed.
引用
收藏
页码:4530 / 4538
页数:9
相关论文
共 32 条
[1]   A FAMILY OF TRANS-ACTING FACTORS WITH DISTINCT REGULATORY FUNCTIONS CONTROL EXPRESSION OF MHC CLASS-II GENES [J].
ACCOLLA, RS ;
DELLABONA, P ;
SCARPELLINO, L ;
CARRA, G ;
SARTORIS, S .
IMMUNOLOGIC RESEARCH, 1990, 9 (01) :20-33
[3]   TRANS-ACTING ELEMENT(S) OPERATING ACROSS SPECIES BARRIERS POSITIVELY REGULATE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES [J].
ACCOLLA, RS ;
SCARPELLINO, L ;
CARRA, G ;
GUARDIOLA, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (04) :1117-1133
[4]   REACTIVATION BY A TRANS-ACTING FACTOR OF HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX IA GENE-EXPRESSION IN INTERSPECIES HYBRIDS BETWEEN AN IA-NEGATIVE HUMAN B-CELL VARIANT AND AN IA-POSITIVE MOUSE B-CELL LYMPHOMA [J].
ACCOLLA, RS ;
CARRA, G ;
GUARDIOLA, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (15) :5145-5149
[5]   AIR-1, A NEWLY FOUND LOCUS ON MOUSE CHROMOSOME-16 ENCODING A TRANS-ACTING ACTIVATOR FACTOR FOR MHC CLASS II GENE-EXPRESSION [J].
ACCOLLA, RS ;
JOTTERANDBELLOMO, M ;
SCARPELLINO, L ;
MAFFEI, A ;
CARRA, G ;
GUARDIOLA, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :369-374
[6]  
ANICHINI A, 1988, J IMMUNOL, V140, P183
[7]   STRUCTURE AND EXPRESSION OF HLA-DQ-ALPHA AND -DX-ALPHA GENES - INTERALLELIC ALTERNATE SPLICING OF THE HLA-DQ-ALPHA GENE AND FUNCTIONAL SPLICING OF THE HLA-DX-ALPHA GENE USING A RETROVIRAL VECTOR [J].
AUFFRAY, C ;
LILLIE, JW ;
KORMAN, AJ ;
BOSS, JM ;
FRECHIN, N ;
GUILLEMOT, F ;
COOPER, J ;
MULLIGAN, RC ;
STROMINGER, JL .
IMMUNOGENETICS, 1987, 26 (1-2) :63-73
[8]   CLASS-II-ANTIGEN-NEGATIVE PATIENT AND MUTANT B-CELL LINES REPRESENT AT LEAST 3, AND PROBABLY 4, DISTINCT GENETIC-DEFECTS DEFINED BY COMPLEMENTATION ANALYSIS [J].
BENICHOU, B ;
STROMINGER, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4285-4288
[9]   ALTERNATIVE SPLICING OF HLA-DQB TRANSCRIPTS AND SECRETION OF HLA-DQ BETA-CHAIN PROTEINS - ALLELIC POLYMORPHISM IN SPLICING AND POLYADENYLYLATION SITES [J].
BRIATA, P ;
RADKA, SF ;
SARTORIS, S ;
LEE, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (03) :1003-1007
[10]  
DIEDRICHS M, 1989, J IMMUNOL, V142, P3275